📻: New Alzheimer's Drug Approval Expands Treatment Options — and Creates Coverage Questions

View in browser ([link removed] )

LinkedIn ([link removed] )

YouTube ([link removed] )

Facebook ([link removed] )

X ([link removed] )

Instagram ([link removed] )

Website ([link removed] )

Friday, July 19, 2024 | The Latest Research, Commentary, and News from Health Affairs

Dear John,

FYI, through Saturday, July 20, we are having a flash sale on Health Affairs Insider membership. Use the code HealthWonkLife for $30 off ([link removed] ) the normal Insider price.

Become an Insider
([link removed] )

Today's Featured Articles

From the Journal: National Health Expenditure Projections, 2023–32: Payer Trends Diverge As Pandemic-Related Policies Fade ([link removed] )

Jacqueline A. Fiore et al.

Forefront: Supreme Court Overrules Chevron Doctrine: Ripple Effects Across Health Care ([link removed] )

Zachary Baron et al.

Forefront: Reconsidering Pharmacy Methadone Distribution For Opioid Use Disorders ([link removed] )

Naba Husain

New Alzheimer's Drug Approval Expands Treatment Options — and Creates Coverage Questions ([link removed] )

Health Affairs' Jeff Byers welcomes Senior Editor Leslie Erdelack to the program to discuss the FDA's recent approval of an Alzheimer's treatment, Lilly’s Kisunla; how private insurers and Medicare might cover the drug; and the emerging new class of drugs surrounding Alzheimer's treatment.

Listen
([link removed] )

health-affairs-wonk-winners-2024_eNewsletter-01 ([link removed] )

HA_Scholar_1st-year_2024_eNewsletter-banner (1) ([link removed] )

Health Affairs Scholar ([link removed] ) is celebrating its one-year anniversary.

The digital journal published its first issue in July 2023 with a dedication to emerging policy trends and global health.

Its presence is growing. Cited by Congress and national media outlets like the New York Times, NPR, and the Los Angeles Times, Scholar has published papers on health care costs, access, quality, and equity. High-impact papers have included:

- Active steps to reduce administrative spending associated with financial transactions in US health care ([link removed] )
- Food and Drug Administration novel drug decisions in 2017: transparency and disclosure prior to and 5 years following approval ([link removed] )
- Has the fall of Roe changed contraceptive access and use? New research from four US states offers critical insights ([link removed] )

Read about Scholar’s first year from Editor-in-Chief Kathryn Phillips on Forefront. ([link removed] )

Also, check out a Health Affairs Scholar ([link removed] ) editorial from Phillips as well.

health-affairs-43-07-order-issue_eNewsletter-banner ([link removed] )

LinkedIn ([link removed] )

YouTube ([link removed] )

Facebook ([link removed] )

X ([link removed] )

Instagram ([link removed] )

Website ([link removed] )

About Health Affairs

Health Affairs is the leading peer-reviewed journal ([link removed] ) at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online.

Sign up for all of our newsletters ([link removed] ) , including Health Affairs Today and Health Affairs Sunday Update.

Project HOPE ([link removed] ) is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Privacy Policy ([link removed] )

Health Affairs, 1220 19th St. NW, Suite 800, Washington, DC 20036, United States, 202-408-6801

Manage preferences ([link removed] )